ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Published Aug 7, 2023

New Journal Impact Factor Score 2.0

Value in Health Regional Issues CoverLawrenceville, NJ, USA—August 7, 2023—Value in Health Regional Issues, the regionally focused journal of ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.

The 2022 impact factor scores were released last month in the Journal Citation Reports, an annual report published by Clarivate Analytics. Value in Health Regional Issues received an impact factor score of 2.0. The journal is indexed in the Health Policy & Services and the Health Care Sciences & Services categories in Clarivate’s Emerging Sources Citation Index. Launched in 2012, Value in Health Regional Issues focuses on the application of HEOR methods in specific regional populations. The journal publishes a diverse mix of original research, systematic literature and scoping reviews, and brief reports that examine the impact of interventions at the individual, healthcare system, community, and policy levels.

“This is a major milestone in the continued growth and expansion of Value in Health Regional Issues,” said Editor-in-Chief Manuel A. Espinoza, MD, MSc, PhD, Pontificia Universidad Católica de Chile, Santiago, Chile. “The journal was first indexed in PubMed in 2016 and included in the Web of Science in 2021. Obtaining an impact factor score is another indication of the growing importance of health economics and outcomes research and reinforces the role Value in Health Regional Issues can play in facilitating evidence-based decisions for patients and healthcare systems around the world.”

In addition, ISPOR is proud to announce that its other journal, Value in Health, recognized for scientific and research excellence in the field, received an impact factor score of 4.5 and has a 5-year impact factor score of 6.2. Value in Health ranks 69th of 380 journals in the Economics category; 21st of 105 journals in the Health Care Sciences & Services category; and 8th of 87 journals in the Health Policy & Services category.

“It is a testament to the dedication and hard work of the Editors-in-Chief, Michael F. Drummond, MCom, DPhil, C. Daniel Mullins, PhD, and Manuel A. Espinoza, MD, MSc, PhD, and the entire team of editors to have both ISPOR journals receive this level of recognition in scholarly publishing,” said Robert Abbott, CEO and Executive Director of ISPOR. “Together, Value in Health and Value in Health Regional Issues not only offer competitive, impactful outlets for authors who are doing research in the HEOR field but also provide rigorous, evidence-based science to a multistakeholder audience that relies on this research to inform healthcare policies and decisions around the world.”

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

ABOUT VALUE IN HEALTH REGIONAL ISSUES
Value in Health Regional Issues (ISSN 2212-1099) is ISPOR’s online, MEDLINE®-indexed journal that publishes articles on health-related topics that impact the health policies and populations in the following regions: (1) Asia; (2) Central and Eastern Europe, Western Asia, and Africa; and (3) Latin America. The journal’s 2022 impact factor score is 2.0.
Website  |  Twitter (@isporjournals)

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2022 impact factor score is 4.5 and its 5-year impact factor score is 6.2. Value in Health is ranked 8th of 87 journals in health policy and services, 21st of 105 journals in healthcare sciences and services, and 69th of 380 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website  | Twitter (@isporjournals)

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×